Reduction in Prevalence of Chronic Pseudomonas aeruginosa Infection at a Regional Pediatric Cystic Fibrosis Center

Pediatric Pulmonology

Volumn 37, Issue 2, 2004, Pages 104-110

  Lee, Tim W R ^a   Brownlee, Keith G ^a   Denton, Miles ^b   Littlewood, James M ^a   Conway, Steven P ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Cohort; Infection status; Intensive eradication regimen; Nebulized antibiotics

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEWBORN SCREENING; NONHUMAN; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CIPROFLOXACIN; CYSTIC FIBROSIS; GREAT BRITAIN; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SEASONS; SPUTUM;

EID: 1642515022     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10401     Document Type: Article

References (29)

1. FitzSimmons S. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
2. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990;116:714-719.
3. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100.
4. Pamukcu A, Bush A, Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropomorphic variables in children with cystic fibrosis. Pediatr Pulmonol 1995;19:10-15.
5. Kosorok MR, Zeng L, West SEH, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001;32:277-287.
6. Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992;12:158-161.
7. Nixon WM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704.
8. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001;183:444-452.
9. Munck A, Bonacorsi S, Mariani-Kurkdjian P, Lebourgeois M, Gérardin M, Brahimi N, Navarro J, Bingen E. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol 2001;32:288-292.
10. Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA. Spread of a betalactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639-642.
11. Jones AM, Govan JRW, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001;358:557-558.
12. Armstrong DS, Nixon GM, Carzino R, Bigham A, Carlin JB, Robins-Browne RM, Grimwood K. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002;166:983-987.
13. Denton M, Kerr K, Mooney L, Keer V, Rajgopal A, Brownlee K, Arundel P, Conway S. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center. Pediatr Pulmonol 2002;34:257-261.
14. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997;100:2.
15. Frederiksen B, Koch C, Høiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999;28:159-166.
16. Lee TWR, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cystic Fibrosis 2003;2:29-34.
17. Colton T. Statistics in medicine. Boston: Little, Brown, and Co.: 1974.
18. Littlewood JM, Littlewood AE, McLaughlin S, Shapiro L, Connolly S. Twenty years continuous neonatal screening in one hospital: progress of 37 patients and their families. Pediatr Pulmonol [Suppl] 1995;12:284.
19. Murray J, Cuckle HS, Taylor G, Littlewood JM, Hewison J. Screening for cystic fibrosis. Health Technol Assess 1999;3:1-104.
20. Cystic Fibrosis Trust. Standards of care: standards for the clinical care of children and adults with cystic fibrosis in the UK. The Cystic Fibrosis Trust's Clinical Standards and Accreditation Group. London: Cystic Fibrosis Trust; 2001.
21. Littlewood JM, Miller MG, Ghoneim AT, Ramsden CH. Nebulised colomycin for early Pseudomonas colonisation in cystic fibrosis. Lancet 1985;1:865.
22. Valerius NH, Koch C, Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991;338:725-726.
23. Szaff M, Høiby N, Flensborg EW. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand 1983;72:651-657.
24. Tummler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, von der Hardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol 1991;29:1265-1267.
25. Høiby N. Microbiology of cystic fibrosis. In: Hodson ME, Geddes DM, editors. Cystic fibrosis. London: Arnold: 1999. p 75-98.
26. Döring G, Ratjen F, Nikolaizik WH. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients. Lancet 2002;359:626.
27. Equi AC, Pike SE, Davies J, Bush A. Use of cough swabs in a cystic fibrosis clinic. Arch Dis Child 2001;85:438-439.
28. Speert DP, Campbell ME, Henry DA, Milner R, Taha F, Gravelle A, Davidson AG, Wong LT, Mahenthiralingam E. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med 2002;166:988-993.
29. Frederiksen B, Koch C, Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-335.